DigitalCommons@USU
metadata only
Synthesizing Microcarriers as a Platform for the Pharmaceutical Delivery of Quercetin for Antiviral Applications
This project aims to increase quercetin bioavailability and antiviral activity against cytomegalovirus (CMV). CMV is the leading viral cause of birth defects in the U.S. Ganciclovir, the current treatment for CMV infection, exhibits cytotoxicity in pregnant women and other immunocompromised populati
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Suppression of Cytomegalovirus Retinitis Utilizing High Dose Intravenous Acyclovir and Oral Zidovudine in Patients With AIDS#910438
- Characterization of rAAV vectors packaging in baculovirusinfected insect cells#1157972
- Flavopiridol in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, or Chronic Myelogenous Leukemia#1072658
- <b>Analysis of quercetin-like compounds as venous vasodilation stimulants: an in-vivo study in rabbits with artificial venous vasoconstriction</b>#422529
- Valganciclovir in Patients With CMV Retinitis and AIDS Who Cannot Take Drugs by Injection#969598
Record · ID 982905
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive